BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 32723259)

  • 41. An Overview of the Synthesis and Antimicrobial, Antiprotozoal, and Antitumor Activity of Thiazole and Bisthiazole Derivatives.
    Borcea AM; Ionuț I; Crișan O; Oniga O
    Molecules; 2021 Jan; 26(3):. PubMed ID: 33504100
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Thiazole Compounds as Antiviral Agents: An Update.
    Singh IP; Gupta S; Kumar S
    Med Chem; 2020; 16(1):4-23. PubMed ID: 31203807
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Synthesis, Molecular Docking Studies and In Silico ADMET Screening of New Heterocycles Linked Thiazole Conjugates as Potent Anti-Hepatic Cancer Agents.
    Rashdan HRM; El-Naggar M; Abdelmonsef AH
    Molecules; 2021 Mar; 26(6):. PubMed ID: 33803823
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Design and optimization of hybrid of 2,4-diaminopyrimidine and arylthiazole scaffold as anticancer cell proliferation and migration agents.
    Zhou W; Huang A; Zhang Y; Lin Q; Guo W; You Z; Yi Z; Liu M; Chen Y
    Eur J Med Chem; 2015; 96():269-80. PubMed ID: 25899332
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Synthesis of Thiazolyl-N-phenylmorpholine Derivatives and their Biological Activities.
    Al-Soliemy AM; Farghaly TA; Abbas EMH; Shaaban MR; Zayed MEM; El-Naggar TBA
    Med Chem; 2021; 17(7):790-805. PubMed ID: 32416682
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Synthesis, Cytotoxicity Evaluation, Molecular Docking and Utility of Novel Chalcones as Precursors for Heterocycles Incorporating Pyrazole Moiety.
    Gomha SM; Abdallah MA; Abbas IM; Kazem MSH
    Med Chem; 2018; 14(4):344-355. PubMed ID: 29065841
    [TBL] [Abstract][Full Text] [Related]  

  • 47. 2,4,5-Trisubstituted Thiazole: A Privileged Scaffold in Drug Design and Activity Improvement.
    Zhang Z; Shu B; Zhang Y; Deora GS; Li QS
    Curr Top Med Chem; 2020; 20(28):2535-2577. PubMed ID: 32942975
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Design, Synthesis, and Evaluation of a New Series of Thiazole-Based Anticancer Agents as Potent Akt Inhibitors.
    Altıntop MD; Sever B; Akalın Çiftçi G; Özdemir A
    Molecules; 2018 May; 23(6):. PubMed ID: 29857484
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Targeting triple-negative breast cancer cells with 6,7-bis(hydroxymethyl)-1H,3H-pyrrolo[1,2-c]thiazoles.
    Santos K; Laranjo M; Abrantes AM; Brito AF; Gonçalves C; Sarmento Ribeiro AB; Botelho MF; Soares MI; Oliveira AS; Pinho e Melo TM
    Eur J Med Chem; 2014 May; 79():273-81. PubMed ID: 24747064
    [TBL] [Abstract][Full Text] [Related]  

  • 50. 1,3-Thiazole Derivatives as a Promising Scaffold in Medicinal Chemistry: A Recent Overview.
    Kushwaha P; Pandey S
    Antiinflamm Antiallergy Agents Med Chem; 2023; 22(3):133-163. PubMed ID: 37997807
    [TBL] [Abstract][Full Text] [Related]  

  • 51. New thiazole carboxamides as potent inhibitors of Akt kinases.
    Chang S; Zhang Z; Zhuang X; Luo J; Cao X; Li H; Tu Z; Lu X; Ren X; Ding K
    Bioorg Med Chem Lett; 2012 Jan; 22(2):1208-12. PubMed ID: 22172705
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Design, synthesis and biological evaluation of a new series of thiazolyl-pyrazolines as dual EGFR and HER2 inhibitors.
    Sever B; Altıntop MD; Radwan MO; Özdemir A; Otsuka M; Fujita M; Ciftci HI
    Eur J Med Chem; 2019 Nov; 182():111648. PubMed ID: 31493743
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Eco-friendly sequential one-pot synthesis, molecular docking, and anticancer evaluation of arylidene-hydrazinyl-thiazole derivatives as CDK2 inhibitors.
    El-Naggar AM; El-Hashash MA; Elkaeed EB
    Bioorg Chem; 2021 Mar; 108():104615. PubMed ID: 33484942
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Anticancer Potential of Thiazole Derivatives: A Retrospective Review.
    Jain S; Pattnaik S; Pathak K; Kumar S; Pathak D; Jain S; Vaidya A
    Mini Rev Med Chem; 2018; 18(8):640-655. PubMed ID: 29173166
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Development of Novel Pyridine-Thiazole Hybrid Molecules as Potential Anticancer Agents.
    Ivasechko I; Yushyn I; Roszczenko P; Senkiv J; Finiuk N; Lesyk D; Holota S; Czarnomysy R; Klyuchivska O; Khyluk D; Kashchak N; Gzella A; Bielawski K; Bielawska A; Stoika R; Lesyk R
    Molecules; 2022 Sep; 27(19):. PubMed ID: 36234755
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Green Synthesis and Molecular Docking of Thiazolyl-thiazole Derivatives as Potential Cytotoxic Agents.
    Gomha SM; Abdelaziz MR; Abdel-Aziz HM; Hassan SA
    Mini Rev Med Chem; 2017; 17(9):805-815. PubMed ID: 28019641
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Novel 2-indolinone thiazole hybrids as sunitinib analogues: Design, synthesis, and potent VEGFR-2 inhibition with potential anti-renal cancer activity.
    Mahmoud HK; Farghaly TA; Abdulwahab HG; Al-Qurashi NT; Shaaban MR
    Eur J Med Chem; 2020 Dec; 208():112752. PubMed ID: 32947227
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of the dichloro-substitution on antiproliferative activity of phthalimide-thiazole derivatives. Rational design, synthesis, elastase, caspase 3/7, and EGFR tyrosine kinase activity and molecular modeling study.
    Donarska B; Świtalska M; Płaziński W; Wietrzyk J; Łączkowski KZ
    Bioorg Chem; 2021 May; 110():104819. PubMed ID: 33752144
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Synthesis and biological evaluation of triterpenoid thiazoles derived from betulonic acid, dihydrobetulonic acid, and ursonic acid.
    Borková L; Frydrych I; Jakubcová N; Adámek R; Lišková B; Gurská S; Medvedíková M; Hajdúch M; Urban M
    Eur J Med Chem; 2020 Jan; 185():111806. PubMed ID: 31677446
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Thiazole: A Review on Chemistry, Synthesis and Therapeutic Importance of its Derivatives.
    Chhabria MT; Patel S; Modi P; Brahmkshatriya PS
    Curr Top Med Chem; 2016; 16(26):2841-2862. PubMed ID: 27150376
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.